Researchers at Ohio State University report that they have developed a new mathematical model for men with advanced prostate cancer who are on androgen deprivation therapy (ADT). This model could guide future treatment decisions for men with advanced prostate cancer, specifically, helping to decide which men would benefit from ADT on an intermittent schedule (IADT).

This model evaluates how men respond to ADT, specifically their tumor characteristics and biology during ADT. The model will provide insight and guidance into which men would benefit from IADT.

This model is the first mathematically based decision aide that uses a man’s personal tumor biology to make treatment decisions.

(From:The Proceedings of The National Academy of Science)

You can hear about this model on Today’s Medical Minute at:

Joel Nowak, M.A., M.S.W.